United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Vanda Pharmaceuticals’ VGT-1849A gets orphan drug designation for polycythemia vera treatment Vanda Pharmaceuticals Inc. has achieved a critical regulatory milestone with the U.S. Food and Drug Administration (FDA) granting… byPallavi MadhirajuDecember 20, 2024